GE HEALTHCARE TECH.INC. (L0T) — Capital Reinvestment Ratio
Latest as of March 2026:
0.61x
GE HEALTHCARE TECH.INC. (L0T) has a Capital Reinvestment Ratio of 0.61x as of March 2026, meaning it reinvests 1% of its operating cash flow (€290.00 Million) in capital expenditures (€178.00 Million). See GE HEALTHCARE TECH.INC. free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.61x
Capex / Operating Cash Flow
Operating Cash Flow
€290.00 Million
EUR
Capital Expenditures
€178.00 Million
EUR
Data as of
Mar 2026
Most recent filing
GE HEALTHCARE TECH.INC. Capital Reinvestment Ratio (2022–2025)
This chart tracks GE HEALTHCARE TECH.INC.'s Capital Reinvestment Ratio across 4 annual periods.
Annual Capital Reinvestment Ratio for GE HEALTHCARE TECH.INC. (2022–2025)
Year-by-year Capital Reinvestment Ratio for GE HEALTHCARE TECH.INC. from 2022 to 2025. For live market cap and broader valuation context, see L0T market cap overview.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.24x | €1.99 Billion | €482.00 Million | ▲ +18.0% |
| 2024 | 0.21x | €1.95 Billion | €401.00 Million | ▲ +11.6% |
| 2023 | 0.18x | €2.10 Billion | €387.00 Million | ▲ +25.6% |
| 2022 | 0.15x | €2.11 Billion | €310.00 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow